INS and Hypoglycemia: As first step towards the development of a fully closed-loop system, also called artificial pancreas, academic research groups and companies investigated algorithms to automatically attenuate or suspend basal insulin infusion based on CGM measurements, e.g. when CGM detects hypoglycemia or CGM trend reveals a risk for imminent hypoglycemia [11, 12].